Ivermectin Success in Argentina: Argentinian Doctor Shares His Ivermectin Experience
Dr. Hector Carvallo graduated from medical school in 1981 — the same year AIDS emerged as a global pandemic. In the first two years, AIDS killed 2 million people. Since 1981, it has claimed the lives of 35 million. While officially retired for a couple of years, the 2020 COVID pandemic brought him out of retirement. Credit: ivmstatus.com “My first fire baptism was with AIDS,” he says. “I have dedicated my professional time to teaching and assisting. I graduated as a professor in 1996, and worked as a professor for the School of Medicine in Buenos Aires, which is public. Later, I was an associate professor of internal medicine for two private schools of medicine until I retired a couple of years ago.” Ivermectin Is a Potent Antiviral Interestingly, Carvallo had experience with ivermectin as an antiviral before the COVID outbreak. Argentinian doctors were using it against dengue fever, which is endemic in Argentina. So, when SARS-CoV-2 emerged, they decided to take another look at the